Fidelity Investments’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,011,617
| Closed | -$96.1M | – | 5802 |
|
|
2024
Q4 | $96.1M | Sell |
10,011,617
-4,558,461
| -31% | -$43.8M | 0.01% | 1138 |
|
|
2024
Q3 | $41.7M | Buy |
14,570,078
+26,431
| +0.2% | +$75.6K | ﹤0.01% | 1448 |
|
|
2024
Q2 | $42.5M | Buy |
14,543,647
+70,278
| +0.5% | +$205K | ﹤0.01% | 1370 |
|
|
2024
Q1 | $46.2M | Buy |
14,473,369
+129,704
| +0.9% | +$414K | ﹤0.01% | 1353 |
|
|
2023
Q4 | $48.2M | Buy |
14,343,665
+1,306,236
| +10% | +$4.39M | ﹤0.01% | 1307 |
|
|
2023
Q3 | $31M | Buy |
13,037,429
+21,098
| +0.2% | +$50.2K | ﹤0.01% | 1430 |
|
|
2023
Q2 | $22.9M | Buy |
13,016,331
+37,251
| +0.3% | +$65.6K | ﹤0.01% | 1589 |
|
|
2023
Q1 | $40M | Buy |
12,979,080
+86,673
| +0.7% | +$267K | ﹤0.01% | 1341 |
|
|
2022
Q4 | $68.3M | Buy |
12,892,407
+343,355
| +3% | +$1.82M | 0.01% | 1120 |
|
|
2022
Q3 | $44.3M | Buy |
12,549,052
+3,143,344
| +33% | +$11.1M | ﹤0.01% | 1291 |
|
|
2022
Q2 | $24.3M | Buy |
9,405,708
+23,554
| +0.3% | +$60.8K | ﹤0.01% | 1575 |
|
|
2022
Q1 | $42M | Buy |
9,382,154
+6,213
| +0.1% | +$27.8K | ﹤0.01% | 1471 |
|
|
2021
Q4 | $63.9M | Buy |
9,375,941
+25,152
| +0.3% | +$171K | ﹤0.01% | 1319 |
|
|
2021
Q3 | $68.2M | Buy |
9,350,789
+27,583
| +0.3% | +$201K | 0.01% | 1281 |
|
|
2021
Q2 | $93.4M | Buy |
9,323,206
+6,981
| +0.1% | +$69.9K | 0.01% | 1146 |
|
|
2021
Q1 | $89M | Buy |
9,316,225
+43,224
| +0.5% | +$413K | 0.01% | 1119 |
|
|
2020
Q4 | $101M | Buy |
9,273,001
+75
| +0% | +$817 | 0.01% | 1025 |
|
|
2020
Q3 | $76.9M | Buy |
+9,272,926
| New | +$76.9M | 0.01% | 1039 |
|